WebFeb 3, 2024 · Pavel Raifeld, Chief Executive Officer of Innoviva, Inc., stated: ... Mr. Raifeld concluded, “2024 was a strong year for us. Our revenues have demonstrated impressive sustainability in a challenging environment, while our operations have remained efficient and robust. We successfully deployed nearly $400 million of capital across a number of ... WebPavel Raifeld is the Chief Executive Officer of Innoviva Inc. Other key executives at Innoviva Inc include CEO of La Jolla Pharmaceutical Larry G. Edwards , Chief …
Pavel Raifeld - Innoviva Inc. - Wall Street Journal
WebMay 21, 2024 · Mr. Raifeld is a seasoned healthcare executive with a strong background in strategy, business development and corporate finance and has focused much of his … WebMay 21, 2024 · Mr. Raifeld replaces Geoff Hulme, who served as the Company’s principal executive officer since May 2024. Prior to joining Innoviva, Pavel Raifeld, CFA, served … family crest search by name
Innoviva Names Pavel Raifeld as Chief Executive Officer
WebJul 11, 2024 · “We are pleased to announce the completion of this transaction. Through the acquisition of Entasis, Innoviva has gained an exciting pipeline, created a new growth channel and diversified its revenue stream,” said Pavel Raifeld, Chief Executive Officer of … WebAug 19, 2024 · “The acquisition of La Jolla strengthens our footprint in the hospital and infectious disease spaces by adding a robust portfolio of marketed products and an excellent team,” said Pavel Raifeld, Chief Executive Officer of Innoviva. “It is also highly complementary to Entasis, providing an established platform to bring SUL-DUR, a ... WebApr 12, 2024 · In other Innoviva news, CEO Pavel Raifeld purchased 3,000 shares of the company’s stock in a transaction that occurred on Friday, March 10th. The stock was acquired at an average cost of $10.87 ... cook handover